The Corpus Luteum is a crucial structure in the female reproductive system, formed from the remnants of the ovarian follicle after ovulation. Composed of specialized cells known as corpus luteum cells, this dynamic endocrine organ plays a pivotal role in regulating reproductive processes. These cells primarily produce progesterone, a hormone essential for the maintenance of the uterine lining during the menstrual cycle. The corpus luteum undergoes cyclic changes, developing into a highly vascularized structure to support its functions. If fertilization occurs, the corpus luteum persists, ensuring a suitable environment for embryonic implantation. Alternatively, in the absence of pregnancy, the corpus luteum degenerates, transforming into the corpus albicans. The intricate interplay of hormones, such as luteinizing hormone and human chorionic gonadotropin, tightly regulates the life cycle of the corpus luteum. Dysregulation of corpus luteum function can lead to reproductive disorders, impacting fertility and menstrual regularity. Research on corpus luteum cells continues to unravel the molecular mechanisms governing their activities, shedding light on fertility-related challenges and potential therapeutic interventions. Understanding the nuances of corpus luteum function is crucial not only for reproductive health but also for broader insights into endocrine regulation in the intricate web of human physiology.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy